STOCK TITAN

TELA Bio: Stonepine reports 0% ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

TELA Bio, Inc.'s amended ownership disclosure reports that Stonepine Capital Management, LLC (investment adviser), Stonepine Capital, L.P. (the Partnership), Stonepine GP, LLC (general partner), and Jon M. Plexico (control person of Stonepine and the general partner) each beneficially owned 0 shares, or 0.0% of the common stock. Each also reported 0 sole and shared voting power and 0 sole and shared dispositive power.

The ownership percentage is calculated using 45,188,230 shares of common stock outstanding as of November 5, 2026, as reported in TELA Bio's Form 10-Q.

Beneficial ownership 0 shares Reported by each of the four reporting persons
Percentage of class 0.0% Reported by each of the four reporting persons
Common shares outstanding 45,188,230 shares As of November 5, 2026
beneficial ownership regulatory
"Amount beneficially owned: Stonepine: 0"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
dispositive power regulatory
"Shared Dispositive Power 0.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Rule 13d-3 regulatory
"beneficial owner, as defined in Rule 13d-3 under the Act"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TELA shares did Stonepine and Jon M. Plexico report owning?

Each of Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC and Jon M. Plexico reported beneficial ownership of 0 shares, or 0.0% of TELA Bio common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





872381108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 45,188,230 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 45,188,230 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 45,188,230 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 45,188,230 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G



Stonepine Capital Management, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Stonepine Capital, L.P.
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:11/13/2026
Stonepine GP, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Jon M. Plexico
Signature:/s/ Jon M. Plexico
Name/Title:Reporting Person
Date:11/13/2026
Exhibit Information

AGREEMENT REGARDING JOINT FILING ON SCHEDULE 13G

Keep reading